ArticleFrontiers in veterinary science2025
Case Report: Concurrent atrial and ventricular septal defect in a young Sphynx cat.
Article in Frontiers in veterinary science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Concurrent atrial septal defect (ASD) and ventricular septal defect (VSD) are rare in cats. A 7-month-old intact female Sphynx cat was presented for evaluation of respiratory distress and exercise intolerance. Thoracic radiographs showed generalized cardiomegaly and pulmonary infiltrates, consistent with cardiogenic pulmonary edema. Transthoracic echocardiography revealed an ostium secundum-type ASD and a perimembranous VSD, with structurally normal atrioventricular valves and annuli. These features supported the diagnosis of concurrent ASD and VSD, rather than an atrioventricular septal defect. Color Doppler echocardiography and agitated saline contrast studies confirmed bidirectional shunting at both defect sites. Additionally, echocardiographic findings were consistent with pulmonary hypertension. As Eisenmenger syndrome was suspected and the owner declined invasive intervention, surgical repair was not performed. Initial treatment with furosemide and supplemental oxygen led to clinical improvement. The owner later discontinued diuretics; however, the cat remained asymptomatic for several months. Cyanosis and erythrocytosis developed approximately 8 months after initial presentation. Follow-up thoracic imaging and Doppler echocardiography demonstrated reduced cardiac silhouette size without recurrent pulmonary edema, right-sided chamber enlargement with right ventricular hypertrophy, and decreased pulmonary-to-systemic flow ratio, consistent with progression of Eisenmenger physiology. Medical management with phlebotomy, sildenafil, clopidogrel, and oxygen supplementation provided temporary stabilization; however, the cat eventually died approximately 1 year after diagnosis, likely due to disease progression and inconsistent therapeutic compliance. Postmortem examination confirmed both septal defects and marked right ventricular hypertrophy, consistent with the ante-mortem imaging findings. Histopathological examination revealed pulmonary vascular remodeling and myocardial fibrosis, indicative of chronic pulmonary hypertension. This report represents the first documented case of concurrent ASD and VSD with Eisenmenger physiology in a cat, with long-term clinical follow-up and postmortem confirmation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.